Recerca

Àrea 3

Trasplantament de fetge i viabilitat de l'empelt

Articles de l'any 2010
Original

Originals publicats: 26

Factor d'impacte: mitjana: 4.26, total: 110.83

  • The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection

    Taura P, Fuster J, Mercadal J, Martinez-Palli G, Fondevila C, Blasi A, Balust J, Garcia-Valdecasas JC
    J HEPATOL. 2010; 52: 340-347. IF: 7.818

  • Matrix Metalloproteinase 2 in Reduced-Size Liver Transplantation: Beyond the Matrix

    Padrissa-Altes S, Zaouali MA, Franco-Gou R, Bartrons R, Boillot O, Rimola A, Arroyo V, Rodes J, Peralta C, Rosello-Catafau J
    AM J TRANSPLANT. 2010; 10: 1167-1177. IF: 6.433

  • Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy

    Brouard S, Puig-Pey I, Lozano JJ, Pallier A, Braud C, Giral M, Guillet M, Londono MC, Oppenheimer F, Campistol JM, Soulillou JP, Sanchez-Fueyo A
    AM J TRANSPLANT. 2010; 10: 2604-2614. IF: 6.433

  • ATG-Fresenius Treatment and Low-Dose Tacrolimus: Results of a Randomized Controlled Trial in Liver Transplantation

    Benitez CE, Puig-Pey I, Lopez M, Martinez-Llordella M, Lozano JJ, Bohne F, Londono MC, Garcia-Valdecasas JC, Bruguera M, Navasa M, Rimola A, Sanchez-Fueyo A
    AM J TRANSPLANT. 2010; 10: 2296-2304. IF: 6.433

  • Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy

    Millan O, Benitez C, Guillen D, Lopez A, Rimola A, Sanchez-Fueyo A, Brunet M
    CLIN IMMUNOL. 2010; 137: 337-346. IF: 3.863

Revisió

Revisions publicades: 4

Factor d'impacte: mitjana: 1.36, total: 5.45

  • Pharmacological strategies against cold ischemia reperfusion injury

    Zaouali MA, BenAbdennebi H, Padrissa-Altes S, Mahfoudh-Boussaid A, Rosello-Catafau J
    EXPERT OPIN PHARMACO. 2010; 11: 537-555. IF: 2.018

  • Minimization of immunosuppression in adult liver transplantation: new strategies and tools

    Londono MC, Lopez MC, Sanchez-Fueyo A
    CURR OPIN ORGAN TRAN. 2010; 15: 685-690. IF: 1.22

Editorials

Editorials publicades: 1

Factor d'impacte: mitjana: 6.43, total: 6.43

  • Is Extracorporeal Support Becoming the New Standard for the Preservation of DCD Grafts?

    Fondevila C
    AM J TRANSPLANT. 2010; 10: 1341-1342. IF: 6.433

Multicèntrics

Multicèntrics publicats: 2

Factor d'impacte: mitjana: 16.87, total: 33.74

  • Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation

    Kuypers DRJ, LeMeur Y, Cantarovich M, Tredger MJ, Tett SE, Cattaneo D, Tonshoff B, Holt DW, Chapman J, VanGelder T
    CLIN J AM SOC NEPHRO. 2010; 5: 341-358. IF: 4.844

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, VanCutsem E, Buyse M
    JAMA-J AM MED ASSOC. 2010; 303: 1729-1737. IF: 28.899

Més articles
Tesis
  • La perfusión normotérmica "Ex - Situ" como continuación de la " Recirculación Normotérmica" en la obtención de injertos hepáticos procedentes de donantes a corazón parado.

    Doctorand: David Calatayud Mizrahi,
    Director/s: Fondevila C, Garcia-Valdecasas JC

  • Noves dianes terapèutiques en el trasplantament de fetge amb empelt de mida reduïda

    Doctorand: Susagna Padrissa Altes,
    Director/s: Peralta C, Rosello-Catafau J

Més tesis
Patents
  • Assessing diagnosis and/or prognosis of the tolerant state in liver transplantation in a human patient comprises obtaining a biological sample from the patient, and measuring the expression levels in the sample of a set of genes

    INST INVESTIGACIONS BIOMEDIQUES SUNYER

  • Diagnosing/prognosing the tolerant state of a patient which, has been or is going to be, subject of a liver transplantation, comprises measuring the expression levels of genes of interest related to liver transplantation in a test sample

    INST INVESTIGACIONS BIOMEDIQUES SUNYER

  • New aqueous solution which lengthens the time in which a tissue or organ can function properly before transplantation comprises carvedilol, tacrolimus, and trimetazidine, useful for the preservation of tissues and organs

    UNIV BARCELONA; INST INVESTIGACIONS BIOMEDIQUES SUNYER

  • New device for preserving hepatic graft in normothermia comprises a receptacle for hepatic graft, an arterial perfusion circuit, and a portal perfusion circuit configured to perfuse a perfusion solution to the hepatic graft

    FUNDACIO PRIVADA CLINIC A RECERCA BIOMED